Arch Biopartners Announces Application to the Turkish Ministry of Health to Conduct Phase II Trial for Treatment of Complications in COVID-19 patients

Ads

You May Also Like

Aduro Biotech Reports Third Quarter 2017 Financial Results

BERKELEY, Calif., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ:ADRO) today reported ...

Cesca Therapeutics Inc. to Present at BIO-Europe Spring® 2018

RANCHO CORDOVA, Calif., March 06, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ:KOOL) ...